Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Verastem cancer drug shows early promise in small study

Wall Street analysts believe Verastem’s drug to now be “competitive” in what’s quickly become one of the most active and crowded areas of oncology research.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Health & Medicine

More from Wednesday 14 October →